Finally, with the discovery of new potential targets or development and application of new drugs in the treatment of those patients, the prognoses of CEBPA mutated AML may be further improved, which may challenge the diagnosis and treatment dogma of the current concept. Here, CEBPA is linked to acute myeloid leukemia.